Related Experiment Videos
Langerhans' cell histiocytosis with bilateral temporal bone involvement
Tobias Kleinjung1, Matthias Woenckhaus, Maike Bachthaler
1Department of Otorhinolaryngology, University of Regensburg, Germany. tobias.kleinjung@klinik.uni-regensburg.de
American Journal of Otolaryngology
|July 29, 2003
Summary
Langerhans' cell histiocytosis (LCH) rarely presents with bilateral temporal bone disease in children. Surgical biopsy is crucial for diagnosing this rare otologic condition and initiating effective chemotherapy for remission.
Area of Science:
- Pediatric Otolaryngology
- Histiocytosis Research
- Rare Disease Etiology
Background:
- Langerhans' cell histiocytosis (LCH) is a rare disorder of unclear etiology, characterized by the proliferation of CD1a-positive Langerhans' cells.
- The clinical presentation of LCH is highly variable, making early diagnosis challenging.
Observation:
- A 2-year-old boy experienced hearing loss and balance issues, indicative of inner ear dysfunction.
- Auditory brainstem-evoked responses confirmed severe bilateral hearing loss, and MRI revealed inflammatory changes and bone erosion in both temporal bones.
Findings:
- Surgical exploration identified LCH tissue in the temporal bones, confirmed by histology.
- Treatment with vinblastine and prednisone chemotherapy resulted in complete and ongoing remission of the disease.
Implications:
- Bilateral temporal bone LCH is an exceptionally rare presentation, potentially mimicking infectious ear diseases.
- Prompt diagnosis via surgical biopsy is essential for effective management and treatment of otologic histiocytosis.
- Early diagnosis and treatment are critical for achieving remission in rare pediatric LCH cases.